Medical Systems - Adv Dev

Abstract

This Program Element (PE) funds development of medical materiel within the early system integration portion of the System Development and Demonstration phase of the acquisition life cycle using 6.4 (Advanced Component Development and Prototype) funding. Program efforts support transition of promising Science and Technology candidate medical technologies (drugs, vaccines, medical devices, diagnostics, and mechanisms for detection and control of disease carrying insects) to larger scale testing in humans for safety and effectiveness. Programs are aligned to meet future force requirements identified within concept documents and organizational structures. This PE also provides funding for Food and Drug Administration (FDA) regulated human clinical trials to gain additional information about safety and effectiveness on the path to licensure for use in humans. These efforts are managed by U.S. Army Medical Materiel Development Activity (USAMMDA) of the U.S. Army Medical Research and Development Command.

Document Details

• Document Type: R2 Budgetary Justification
• Publication Date: Oct 01, 2024
• Source ID: 0603807A_4_2040_PB_2024
• Change Summary Explanation: Decreased funding to support higher Army priorities.
• Service Agency Name: Army

Entities

Organizations

• United States Army

Tags

DTIC Thesaurus Topics

• Acquisition
• Biomedical Research
• Clinical Trials
• Combat Casualty Care
• Cost Analysis
• Health Services
• Infectious Diseases
• Life Cycles
• Medical Countermeasures
• Military Hospitals
• Organizational Structure
• Product Development
• Project Management
• Test And Evaluation
• Warfare
• Wound Infections
• Wounds And Injuries

Readers

• Infectious Disease/Epidemiology
• Military Science and Technology Research and Modernization.
• Software Engineering

Technology Areas

• Biotechnology